BackPrecigen Overview

Precigen Profit Margin

Precigen (PGEN) has a profit margin of -392.81%, below the Healthcare sector average of 21.34%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

36.51%
↑ 101.17% YoY

As of Jun 2026

Annual Profit Margin (TTM)

-392.81%
↑ 86.31% YoY

Trailing 12 months ending Jun 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Precigen (PGEN) FAQ

Precigen (PGEN) currently reports a profit margin of -392.81% as of June 2026. That compares with -2868.66% in the prior-year period — up 86.3% year over year. That is below the Healthcare sector average of 21.34%. Use the charts on this page to explore Precigen's profit margin history and peer comparisons.

Precigen's profit margin increased from -2868.66% to -392.81% — a 86.3% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Precigen's profit margin of -392.81% is lower than the Healthcare sector average of 21.34%. That is roughly 1941.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Precigen's current -392.81% should be judged against Healthcare norms (sector average: 21.34%) and against PGEN's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -392.81%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.34%. From there, open related valuation or income-statement pages for Precigen, and consider following PGEN for alerts when major investors trade the stock.